Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORAZEPAM vs LOVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORAZEPAM vs LOVASTATIN: Safety Overview

Metric LORAZEPAM LOVASTATIN
Total FAERS Reports 33,404 1,387
Deaths Reported 6,187 204
Death Rate 18.5% 14.7%
Hospitalizations 15,431 287
Average Patient Age 49.8 yrs 60.2 yrs
% Female Patients 60.8% 55.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 14, 2006
Manufacturer Hikma Pharmaceuticals USA Inc. Preferred Pharmaceuticals, Inc.
Route INTRAMUSCULAR ORAL
Marketing Status Prescription Discontinued